logo

For the Inventor, By the Inventor

Lawrenceville, NJ, United States of America

Donna J Cabral-Lilly

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Celator Pharmaceuticals, Inc., The Liposome Company, Inc., Transave Limited. Active years: 2000-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donna J Cabral-Lilly. Retrieved from https://idiyas.com/inventor/donna-j-cabral-lilly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9

 

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 211(Granted Patents)


Location History:

  • Lawrenceville, NJ (US) (2000)
  • Princeton, NJ (US) (2002 - 2009)
  • Pennington, NJ (US) (2018 - 2020)

Company Filing History:

goldMedal3 out of 25 
 
Celator Pharmaceuticals, Inc.
 patents
silverMedal3 out of 115 
 
The Liposome Company, Inc.
 patents
bronzeMedal2 out of 7 
 
Transave Limited
 patents
4. 1 out of 1 
 
Elan Pharmaceuticalstechnologies, Inc.
 patent

Years Active: 2000-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 10835492 - Method of lyophilizing liposomes (2020-11-17),
2. 10166184 - Method of lyophilizing liposomes (2019-01-01),
3. 10028912 - Method of lyophilizing liposomes (2018-07-24),
4. 7491409 - Encapsulation of bioactive complexes in liposomes (2009-02-17),
5. 7060291 - Modular targeted liposomal delivery system (2006-06-13),
6. 6339069 - Peptide-lipid conjugates, liposomes and lipsomal drug delivery (2002-01-15),
7. 6143716 - Liposomal peptide-lipid conjugates and delivery using same (2000-11-07),
8. 6087325 - Peptide-lipid conjugates (2000-07-11),
9. 6015716 - Detection of endotoxin levels in liposomes, lipid bilayers and lipid (2000-01-18),

Title: Donna J Cabral-Lilly: Innovator in Liposomal Formulations

Introduction

Donna J Cabral-Lilly is a prominent inventor based in Lawrenceville, NJ (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the area of liposomes. With a total of 9 patents to her name, her work has had a substantial impact on drug delivery systems.

Latest Patents

Among her latest patents is a method of lyophilizing liposomes. This patent discloses lyophilized liposomal formulations that contain two or more encapsulated drugs. These formulations are notable for their superior drug retention profiles and their ability to maintain size distribution following lyophilization and reconstitution. This innovation is crucial for enhancing the efficacy of drug delivery.

Career Highlights

Throughout her career, Donna has worked with notable companies such as The Liposome Company, Inc. and Celator Pharmaceuticals, Inc. Her expertise in liposomal technology has positioned her as a leader in the pharmaceutical industry.

Collaborations

Donna has collaborated with esteemed colleagues, including Andrew S Janoff and Paul R Meers. These partnerships have further advanced her research and development efforts in liposomal formulations.

Conclusion

Donna J Cabral-Lilly's contributions to the field of liposomal formulations demonstrate her innovative spirit and dedication to improving drug delivery systems. Her patents and collaborations reflect her significant role in advancing pharmaceutical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…